Thursday, March 26, 2026
Robin Weber Symposium: Updates in Psoriasis Management
GS210 8:00 AM - 9:00 AM
Speaker: Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, FSDNP
This session will provide a comprehensive overview of the management of psoriasis using an interactive, and fun case-based format. We will review the pathogenesis and clinical presentation of the many variants of psoriasis. We will identify and explain the immune-based targets that provide therapeutic targets, focusing on the newest psoriasis treatments. Finally, we will discuss patient education to enhance understanding and adherence to therapy and improved quality of life.
Speaker: Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, FSDNP
This session will provide a comprehensive overview of the management of psoriasis using an interactive, and fun case-based format. We will review the pathogenesis and clinical presentation of the many variants of psoriasis. We will identify and explain the immune-based targets that provide therapeutic targets, focusing on the newest psoriasis treatments. Finally, we will discuss patient education to enhance understanding and adherence to therapy and improved quality of life.
Acne Management
GS220 9:00 AM - 10:00 AM
Speaker: Carla Torres-Zegarra, MD
Speaker: Carla Torres-Zegarra, MD
NP241 - TBD
NP241 1:00 PM - 2:00 PM
Lichen Planus: Updates on Diagnosis and Treatments
NP251 3:00 PM - 4:00 PM
Speaker: Matthew Vesely, MD, PhD
This presentation provides an up-to-date overview of lichen planus, highlighting advances in understanding its pathogenesis and clinical variants. Dr. Vesely will discuss current and emerging treatment strategies—from topical and systemic immunomodulators to novel targeted therapies—emphasizing a practical, evidence-based approach to managing this challenging inflammatory skin disease.
Speaker: Matthew Vesely, MD, PhD
This presentation provides an up-to-date overview of lichen planus, highlighting advances in understanding its pathogenesis and clinical variants. Dr. Vesely will discuss current and emerging treatment strategies—from topical and systemic immunomodulators to novel targeted therapies—emphasizing a practical, evidence-based approach to managing this challenging inflammatory skin disease.
Cutaneous lupus: Updates on Diagnosis and Treatments
NP261 4:00 PM - 5:00 PM
Speaker: Matthew Vesely, MD, PhD
This session will review recent progress in the diagnosis and management of cutaneous lupus erythematosus, integrating clinical, histopathologic, and molecular insights. Dr. Vesely will outline modern classification frameworks, discuss biomarkers guiding precision diagnosis, and present new therapeutic developments, including biologic and immune-targeted approaches designed to improve outcomes and quality of life for patients with lupus skin disease.
Speaker: Matthew Vesely, MD, PhD
This session will review recent progress in the diagnosis and management of cutaneous lupus erythematosus, integrating clinical, histopathologic, and molecular insights. Dr. Vesely will outline modern classification frameworks, discuss biomarkers guiding precision diagnosis, and present new therapeutic developments, including biologic and immune-targeted approaches designed to improve outcomes and quality of life for patients with lupus skin disease.
Friday, March 27, 2026
Artificial Intelligence Enhances Skin Allergy Testing
GS310 8:00 AM - 9:00 AM
Speaker: Mikolaj A. Wieczorek, M.S.
Allergic contact dermatitis is an inflammatory skin response that affects about 1 in 5 people and is diagnosed using patch testing (PT). Traditional PT requires three in-person clinical appointments spread over 5 days using standardized allergen panels that are not tailored to a patient’s unique risk profile. The allergens are typically applied to the patient’s back, which necessitates that the test vehicle be removed and read by trained medical staff. This process creates long waits, specialist shortages, and substantial financial and logistical burdens for patients. Our personalized, AI-assisted approach reimagines PT by transitioning it from provider-led to patient-centered testing. Patches are placed on the volar forearm, allowing patients to easily access the test site and document reactions using a smartphone app. This solution expands access and reduces test burden while supporting providers through evidence-based allergen recommendations, AI-assisted interpretation, and automated documentation that together guide diagnosis.
Speaker: Mikolaj A. Wieczorek, M.S.
Allergic contact dermatitis is an inflammatory skin response that affects about 1 in 5 people and is diagnosed using patch testing (PT). Traditional PT requires three in-person clinical appointments spread over 5 days using standardized allergen panels that are not tailored to a patient’s unique risk profile. The allergens are typically applied to the patient’s back, which necessitates that the test vehicle be removed and read by trained medical staff. This process creates long waits, specialist shortages, and substantial financial and logistical burdens for patients. Our personalized, AI-assisted approach reimagines PT by transitioning it from provider-led to patient-centered testing. Patches are placed on the volar forearm, allowing patients to easily access the test site and document reactions using a smartphone app. This solution expands access and reduces test burden while supporting providers through evidence-based allergen recommendations, AI-assisted interpretation, and automated documentation that together guide diagnosis.
Infantile Hemangiomas
GS320 9:00 AM - 10:00 AM
Speaker: Sofia Guelfand Warnken, MD
Speaker: Sofia Guelfand Warnken, MD
NP Business Meeting
10:00 AM - 10:30 AM
Improvement or Resolution of Psoriasis in Two Distinct Cases Following Autohemotherapy (AHT) or/and Plasma Rich Fibrin (PRF)
NP331 10:30 AM - 11:30 AM
Speakesr: Galina Warren, ANP, DCNP, MSN and Jessica Buzenas, MD
Our experience with Autohemotherapy (AHT) and Plasma-Rich Fibrin (PRF) as an alternative therapeutic approach to treatment of Psoriasis. AHT involves injecting a small amount of a patient's own blood, drawn from a vein, into gluteal muscle; thereby, triggering systemic immunomodulatory effects. PRF intralesional (IL) or subcutaneous (SQ) was used to augment AHT in case of extensive psoriatic plaques coverage.
Speakesr: Galina Warren, ANP, DCNP, MSN and Jessica Buzenas, MD
Our experience with Autohemotherapy (AHT) and Plasma-Rich Fibrin (PRF) as an alternative therapeutic approach to treatment of Psoriasis. AHT involves injecting a small amount of a patient's own blood, drawn from a vein, into gluteal muscle; thereby, triggering systemic immunomodulatory effects. PRF intralesional (IL) or subcutaneous (SQ) was used to augment AHT in case of extensive psoriatic plaques coverage.
NP 351 - TBD
NP351 1:00 PM - 2:00 PM
Case Conundrums: Confusing Cutaneous "Skin-erios" in Kids
NP361 2:00 PM - 3:00 PM
Speakers: Alann Bree, MD and Joseph Lam, MD
Have you ever been stumped by a clinical scenario when caring for a pediatric dermatology patient? Then this session is for you. The presenters will review perplexing cases from their careers as well as confusing cases submitted by conference attendees.
Speakers: Alann Bree, MD and Joseph Lam, MD
Have you ever been stumped by a clinical scenario when caring for a pediatric dermatology patient? Then this session is for you. The presenters will review perplexing cases from their careers as well as confusing cases submitted by conference attendees.
Diagnostic Pearls: More Than Skin Deep
NP371 3:15 PM - 4:15 PM
Speaker: Alann Bree, MD
Skin disease is associated with significant psychosocial impacts. This session will summarize these impacts, how to assess them, and how to best address them as a dermatology practitioner who is committed to holistic patient care.
Speaker: Alann Bree, MD
Skin disease is associated with significant psychosocial impacts. This session will summarize these impacts, how to assess them, and how to best address them as a dermatology practitioner who is committed to holistic patient care.
Diagnosis at Your Fingertips
NP381 4:15 PM - 5:15 PM
Speaker: Joseph Lam, MD
Speaker: Joseph Lam, MD